tiprankstipranks
Trending News
More News >
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO

Organogenesis Holdings (ORGO) Stock Statistics & Valuation Metrics

Compare
451 Followers

Total Valuation

Organogenesis Holdings has a market cap or net worth of $440.18M. The enterprise value is $486.99M.
Market Cap$440.18M
Enterprise Value$486.99M

Share Statistics

Organogenesis Holdings has 126,853,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding126,853,540
Owned by Insiders
Owned by Institutions

Financial Efficiency

Organogenesis Holdings’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.09%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.09%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee554.71K
Profits Per Employee990.79
Employee Count869
Asset Turnover0.97
Inventory Turnover4.41

Valuation Ratios

The current PE Ratio of Organogenesis Holdings is 489.38. Organogenesis Holdings’s PEG ratio is -0.27.
PE Ratio489.38
PS Ratio0.00
PB Ratio1.32
Price to Fair Value1.09
Price to FCF-38.71
Price to Operating Cash Flow14.07
PEG Ratio-0.27

Income Statement

In the last 12 months, Organogenesis Holdings had revenue of 482.04M and earned 861.00K in profits. Earnings per share was -0.01.
Revenue482.04M
Gross Profit366.30M
Operating Income-1.28M
Pretax Income-2.81M
Net Income861.00K
EBITDA15.76M
Earnings Per Share (EPS)-0.01

Cash Flow

In the last 12 months, operating cash flow was 4.43M and capital expenditures -11.44M, giving a free cash flow of -7.00M billion.
Operating Cash Flow4.43M
Free Cash Flow-7.00M
Free Cash Flow per Share-0.06

Dividends & Yields

Organogenesis Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.60
52-Week Price Change26.80%
50-Day Moving Average3.79
200-Day Moving Average3.60
Relative Strength Index (RSI)45.72
Average Volume (3m)1.49M

Important Dates

Organogenesis Holdings upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date

Financial Position

Organogenesis Holdings as a current ratio of 3.69, with Debt / Equity ratio of 46.60%
Current Ratio3.69
Quick Ratio3.35
Debt to Market Cap0.02
Net Debt to EBITDA-5.85
Interest Coverage Ratio-0.83

Taxes

In the past 12 months, Organogenesis Holdings has paid -3.67M in taxes.
Income Tax-3.67M
Effective Tax Rate1.31

Enterprise Valuation

Organogenesis Holdings EV to EBITDA ratio is 20.88, with an EV/FCF ratio of 78.81.
EV to Sales0.68
EV to EBITDA20.88
EV to Free Cash Flow78.81
EV to Operating Cash Flow23.16

Balance Sheet

Organogenesis Holdings has $109.97M in cash and marketable securities with $42.63M in debt, giving a net cash position of -$67.33M billion.
Cash & Marketable Securities$109.97M
Total Debt$42.63M
Net Cash-$67.33M
Net Cash Per Share-$0.53
Tangible Book Value Per Share$2.61

Margins

Gross margin is 76.71%, with operating margin of -0.27%, and net profit margin of 0.18%.
Gross Margin76.71%
Operating Margin-0.27%
Pretax Margin-0.58%
Net Profit Margin0.18%
EBITDA Margin3.27%
EBIT Margin-0.26%

Analyst Forecast

The average price target for Organogenesis Holdings is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside89.27% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast5.35%
EPS Growth Forecast-432.51%

Scores

Smart Score6
AI Score43
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis